HighTower Advisors’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
RP
HighTower Advisors's ACLS Position: Q2 2026 in Review
HighTower Advisors reduced its Axcelis (ACLS) stake by 17% in Q2 2026, selling an estimated $187K and leaving 6,107 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #2148.
HighTower Advisors first reported a position in ACLS in Q4 2022 and has held it in 13 quarters since. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.
- HighTower Advisors held 6,107 shares of Axcelis worth $1.16M as of Q2 2026.
- HighTower Advisors sold 1,260 Axcelis shares in Q2 2026, an estimated $187K.
- Axcelis made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #2148 holding.
- HighTower Advisors first reported a position in Axcelis in Q4 2022 and has held it in 13 quarters since.
- 441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.
Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.